samedan logo
 
 
spacer
home > pmps > autumn 2020 > the automation of change
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Automation of Change

Medication non-adherence among patients is a complex issue, and it remains a pressing matter for the NHS. Figures suggest that in the EU alone nearly 200,000 deaths occur each year due to missed doses of medication and that 500 million is the yearly cost to the NHS of a patient not taking their medication properly (1-2). It is clear that patient adherence levels need to improve drastically to improve patient outcomes and lessen the burden on the health service.

Non-adherence within primary care can be a particular problem as it is often the patient or carer who is responsible for administering medication after receiving a prescription from a healthcare professional. One of the many ways to support adherence is creating a culture of education fostered around patient adherence to support the public in this role. Community pharmacists are ideally placed to do this but they need more time and resources to build better interpersonal relationships with members of the public to help them understand their medication regimes. Industry pioneers see technology as an innovative and attainable solution to support community pharmacies in this role. Automation in pharmacy will free up pharmacists' time, allowing them to focus more on patient care.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Cyrus Hodivala is the Medication Adherence Sales Director at Omnicell. Founded in 1992, Omnicell is a leading provider of medication and supply management solutions to the global healthcare market. The company specialises in improving patient safety from hospital to home, and using better management of supplies and medications to improve standards of care by allowing clinicians to spend more time with their patients.
spacer
Cyrus Hodivala
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Thermo Fisher Scientific Adds Patterned Microchip-based Technology to Liquid Chromatography Portfolio

PHILADELPHIA ASMS 2021 (November 1, 2021) Thermo Fisher Scientific, the world leader in serving science, today announced its acquisition of Belgium-based PharmaFluidics, the developer of the μPAC range of micro-chip-based chromatography column.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement